جامعة النجاح الوطنية
An-Najah National University
Pharmacology
Duration: 24 Months (2 Years)
Degree Awarded: MSc

Career Opportunities

Graduates of the Master’s Program in Pharmacology are well-prepared for diverse roles across the pharmaceutical, academic, clinical, and research sectors, both locally and internationally.

Pharmaceutical Industry Sector

The program equips graduates with the knowledge and skills needed to work in:

  • Drug discovery and development

  • Preclinical and clinical pharmacology

  • Pharmacovigilance and drug safety

  • Medical affairs and regulatory support

Graduates can also serve as pharmacology experts and consultants in local, regional, and international pharmaceutical and biotech companies.

Academic Work

Graduates are qualified to pursue academic careers in universities and colleges, teaching pharmacology and related courses to students in programs such as Pharmacy and Doctor of Pharmacy, Pharmacy, Medicine, Nursing, Medical Laboratory Sciences, dentistry and other allied health programs

Research Institutions

The program prepares graduates to join research teams in pharmaceutical and medical research centers, university and institute research laboratories and non-governmental and international organizations involved in health and biomedical research. They can also contribute to basic, translational, and clinical pharmacology projects at local, regional, and global levels.

Medical and Health Institutions

For physicians, pharmacists, and other health professionals, the program enhances their scientific and clinical competence in pharmacology, enabling them to optimize pharmacotherapy and rational drug use, improve clinical decision-making and patient outcomes, and strengthen their professional profile, evaluations, and career progression within healthcare institutions

Insurance Agencies

Graduates can work with insurance companies and health funding bodies as drug and pharmacotherapy reviewers, experts in evaluating medical prescriptions and treatment protocols and advisors in developing drug-related coverage policies and cost-effectiveness strategies.


© 2026 An-Najah National University